4//SEC Filing
Nash Huw M. 4
Accession 0001415889-24-016008
CIK 0001623526other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:41 PM ET
Size
8.1 KB
Accession
0001415889-24-016008
Insider Transaction Report
Form 4
Nash Huw M.
COO & CBO
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-03-27+60,000→ 60,000 totalExercise: $14.17Exp: 2034-03-26→ Common Stock (60,000 underlying) - Award
Restricted Stock Units
2024-03-27+40,000→ 40,000 totalExp: 2028-03-15→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]The option vested or vests as to 1/48 of the total award on April 15, 2024, with 1/48 vesting on each monthly anniversary thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The award vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001780085
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:41 PM ET
- Size
- 8.1 KB